Medical devices, healthcare technology and the business of care
510(k) clearance · K260687

VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System.

Vivachek Biotech (Hangzhou) Co., Ltd. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK260687

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 10/09/2026 for VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System., submitted by Vivachek Biotech (Hangzhou) Co., Ltd. of Hangzhou, CN, under 510(k) number K260687. The application was received 03/03/2026 and reviewed under regulation 862.1345 in the Clinical Chemistry specialty, with classification product code NBW and subsequent product code JIN. SESE in this context is a 510(k) clearance, not a premarket approval.

The record describes a traditional 510(k) that was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. A separate FDA over-the-counter listing for the same document number gives an effective date of 10/13/2026 and describes the test type as glucose monitoring devices cleared for home use. The source does not include the decision summary, performance data, or the specific technological differences from the predicate device.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Clinical Chemistry
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260687
Regulatory pathway
510(k) premarket notification
Product code
NBW
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Test, Blood Glucose, Over The Counter.

Product code
NBW
FDA device class
2

FDA decision timeline

  1. K260687 received

    Application receipt date recorded by FDA.

  2. K260687 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NBW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Vivachek Biotech (Hangzhou) Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hangzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records